TSXV: MGRO | OTCQB: MGROF | FRA: 0C0

Licensing Partnerships

MustGrow’s Licensing Partnerships

 MustGrow’s partnership strategy through commercial licensing is to provide exclusive commercial access to its technology to organizations that have the know-how and capital to complete R&D, registration work, and once a product has been approved for sale, to sell the product in their respective markets and territories.  For MustGrow’s share of the partnership, it will receive payments and future royalties on sales.  Currently, the MustGrow signed one commercial license agreement with Bayer.  

Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, Bayer aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2020, Bayer employed around 100,000 people and had sales of 41.4 billion euros. R&D expenses before special items amounted to 4.9 billion euros. For more information, go to www.bayer.com.

View the Technology Pipeline